Thoracic Oncologists are dedicated medical experts who specialize in diagnosing and treating cancers of the chest region, including lung cancer, esophageal cancer, and cancers of the pleura and mediastinum. These cancers often present unique challenges due to their location and potential impact on breathing and circulation. Thoracic oncologists rely on advanced diagnostic tools like CT scans, PET scans, and biopsies to accurately identify the cancer type and stage. Based on this information, they craft personalized treatment plans that may involve chemotherapy, radiation therapy, surgery, immunotherapy, or targeted drugs.
Thoracic oncologists provide essential support in managing symptoms such as chest pain, shortness of breath, and fatigue, improving both survival and quality of life. They work closely with a multidisciplinary team—pulmonologists, thoracic surgeons, radiation oncologists, and supportive care providers—to ensure patients receive integrated, comprehensive care. These specialists also contribute to ongoing research, clinical trials, and the development of new therapies for thoracic malignancies. Their role is critical not only in fighting the disease but also in guiding patients through every phase of their journey with compassion and expertise. They often serve as a primary point of contact for patients and families, helping them make informed decisions. Their dedication to both treatment and support makes them integral to the cancer care team.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China